NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE4025.35184.6 (+4.81 %)
PREV CLOSE ( ) 3840.75
OPEN PRICE ( ) 3855.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29373
TODAY'S LOW / HIGH ( )3840.75 4040.00
52 WK LOW / HIGH ( )3050.15 4072.35
NSE4016.35172.55 (+4.49 %)
PREV CLOSE( ) 3843.80
OPEN PRICE ( ) 3850.00
BID PRICE (QTY) 4016.35 (2062)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1155173
TODAY'S LOW / HIGH( ) 3836.05 4039.00
52 WK LOW / HIGH ( )3051 4074.4
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-10 1990
Management Info
Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 66966300

Email mail@divislabs.com

Website www.divislabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE, MCX
NEWS
26Apr Divi's Laboratories surges on planning
Divi's Laboratories is currently trading at Rs. 3988.50, up by 147.75 po..
25Apr Divi's Laboratories planning for capac
Divi's Laboratories is in the process of entering into a long-term suppl..
25Apr Divi’s Laboratories informs about disc
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..
11Apr Divi's Laboratories informs about cert
Divi's Laboratories has informed that it enclosed certificate dated Apri..
30Mar Divi’s Laboratories informs about clos
Pursuant to the Company’s Code of Conduct for Prevention of Insider Trad..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit358018081.5
Gross Profit 4900 23541
Operating Profit 585026966.9
Net Sales 1808076253
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 8278.10 (1.76%)
M.Cap (Rs. in Cr)19064.98
Abbott India (BSE)
 25864.85 (0.54%)
M.Cap (Rs. in Cr)54961.00
Astrazeneca Pharma I (BSE)
 5415.40 (2.18%)
M.Cap (Rs. in Cr)13538.50
Glaxosmithkline Phar (BSE)
 2132.75 (3.26%)
M.Cap (Rs. in Cr)36130.07
Ajanta Pharma (BSE)
 2200.70 (2.94%)
M.Cap (Rs. in Cr)27710.26
MORE
Shareholding Pattern
PROMOTERS 51.92%
MUTUAL FUNDS/UTI 14.28%
NON-INSTITUTION 11.19%
FI/BANKS/INSURANCE 7.24%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.